Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTGX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTGX
Protagonist Therapeutics, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
PTGX
with
LLY
Uncorrelated: r 0.11 · 500D.
No shared co-movers.
PTGX, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
PTGX
Protagonist Therapeutics, Inc
Change
144.19
▼
−0.11%
· post 144.17
Mkt cap
$9.4B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
LLY
ELI Lilly & Co
Change
1,412.87
▲
+2.85%
· post 1,417.05
Closed
Oct 30 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Oct 30 '26
PTGX
Protagonist Therapeutics, Inc
vs
LLY
ELI Lilly & Co
144.19
▼
−0.11%
post 144.17
Price
1,412.87
▲
+2.85%
post 1,417.05
$9.4B
Mkt cap
$1.3T
Q2 FY26
$213M
Revenue
$24.4B
Q3 FY26
FY25
$46M
Revenue
$65.2B
FY25
Change
Change
PTGX
144.19
▼
−0.11%
vs
LLY
1,412.87
▲
+2.85%
Closed
Oct 30 '26